FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225960017> ?p ?o ?g. }

• W4225960017 endingPage "2037" @default.
• W4225960017 startingPage "2030" @default.
• W4225960017 abstract "The anti-CD33 antibody lintuzumab has modest activity against acute myeloid leukemia (AML). To increase its potency, lintuzumab was conjugated to actinium-225 (225Ac), a radionuclide yielding 4 α-particles. This first-in-human, phase I trial was conducted to determine the safety, pharmacology, and biological activity of 225Ac-lintuzumab.Eighteen patients (median age, 64 years; range, 45-80) with relapsed or refractory AML received a single infusion of 225Ac-lintuzumab at activities of 18.5 to 148 kBq/kg.The maximum tolerated dose was 111 kBq/kg. Dose-limiting toxicities included myelosuppression lasting > 35 days in one patient receiving 148 kBq/kg and death from sepsis in two patients treated with 111 and 148 kBq/kg. Myelosuppression was the most common toxicity. Significant extramedullary toxicities were limited to transient grade 3 liver function abnormalities. Pharmacokinetics were determined by gamma counting serial whole blood, plasma, and urine samples at energy windows for the 225Ac daughters, francium-221 and bismuth-213. Two-phase elimination kinetics were seen with mean plasma t1/2 - α and t1/2 - β of 1.9 and 38 hours, respectively. Peripheral blood blasts were eliminated in 10 of 16 evaluable patients (63%) but only at doses of ≥ 37 kBq/kg. Bone marrow blasts were reduced in 10 of 15 evaluable patients (67%), including 3 patients with marrow blasts ≤ 5% and one patient with a morphologic leukemia-free state.Therapy for AML with the targeted α-particle generator 225Ac-lintuzumab was feasible with an acceptable safety profile. Elimination of circulating blasts or reductions in marrow blasts were observed across all dose levels." @default.
• W4225960017 created "2022-05-05" @default.
• W4225960017 creator A5006680533 @default.
• W4225960017 creator A5010076893 @default.
• W4225960017 creator A5021277289 @default.
• W4225960017 creator A5044188379 @default.
• W4225960017 creator A5051627249 @default.
• W4225960017 creator A5055703943 @default.
• W4225960017 creator A5063044283 @default.
• W4225960017 creator A5064294460 @default.
• W4225960017 creator A5064702410 @default.
• W4225960017 creator A5068912186 @default.
• W4225960017 creator A5074412536 @default.
• W4225960017 creator A5088396640 @default.
• W4225960017 date "2022-03-03" @default.
• W4225960017 modified "2023-10-14" @default.
• W4225960017 title "Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab" @default.
• W4225960017 cites W1557532626 @default.
• W4225960017 cites W1821781403 @default.
• W4225960017 cites W1884159022 @default.
• W4225960017 cites W1978689317 @default.
• W4225960017 cites W1980796692 @default.
• W4225960017 cites W1997928845 @default.
• W4225960017 cites W2016103085 @default.
• W4225960017 cites W2041821006 @default.
• W4225960017 cites W2076571981 @default.
• W4225960017 cites W2096729637 @default.
• W4225960017 cites W2097907366 @default.
• W4225960017 cites W2137881702 @default.
• W4225960017 cites W2148047805 @default.
• W4225960017 cites W2159507916 @default.
• W4225960017 cites W2163123363 @default.
• W4225960017 cites W2166118327 @default.
• W4225960017 cites W2171140185 @default.
• W4225960017 cites W2226490553 @default.
• W4225960017 cites W2467018059 @default.
• W4225960017 cites W267300006 @default.
• W4225960017 cites W2801866393 @default.
• W4225960017 cites W2889801464 @default.
• W4225960017 cites W4376595466 @default.
• W4225960017 doi "https://doi.org/10.1158/1078-0432.ccr-21-3712" @default.
• W4225960017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35247915" @default.
• W4225960017 hasPublicationYear "2022" @default.
• W4225960017 type Work @default.
• W4225960017 citedByCount "16" @default.
• W4225960017 countsByYear W42259600172022 @default.
• W4225960017 countsByYear W42259600172023 @default.
• W4225960017 crossrefType "journal-article" @default.
• W4225960017 hasAuthorship W4225960017A5006680533 @default.
• W4225960017 hasAuthorship W4225960017A5010076893 @default.
• W4225960017 hasAuthorship W4225960017A5021277289 @default.
• W4225960017 hasAuthorship W4225960017A5044188379 @default.
• W4225960017 hasAuthorship W4225960017A5051627249 @default.
• W4225960017 hasAuthorship W4225960017A5055703943 @default.
• W4225960017 hasAuthorship W4225960017A5063044283 @default.
• W4225960017 hasAuthorship W4225960017A5064294460 @default.
• W4225960017 hasAuthorship W4225960017A5064702410 @default.
• W4225960017 hasAuthorship W4225960017A5068912186 @default.
• W4225960017 hasAuthorship W4225960017A5074412536 @default.
• W4225960017 hasAuthorship W4225960017A5088396640 @default.
• W4225960017 hasBestOaLocation W42259600171 @default.
• W4225960017 hasConcept C112705442 @default.
• W4225960017 hasConcept C126322002 @default.
• W4225960017 hasConcept C2778461978 @default.
• W4225960017 hasConcept C2778729363 @default.
• W4225960017 hasConcept C2780007613 @default.
• W4225960017 hasConcept C29730261 @default.
• W4225960017 hasConcept C71924100 @default.
• W4225960017 hasConcept C90924648 @default.
• W4225960017 hasConcept C98274493 @default.
• W4225960017 hasConceptScore W4225960017C112705442 @default.
• W4225960017 hasConceptScore W4225960017C126322002 @default.
• W4225960017 hasConceptScore W4225960017C2778461978 @default.
• W4225960017 hasConceptScore W4225960017C2778729363 @default.
• W4225960017 hasConceptScore W4225960017C2780007613 @default.
• W4225960017 hasConceptScore W4225960017C29730261 @default.
• W4225960017 hasConceptScore W4225960017C71924100 @default.
• W4225960017 hasConceptScore W4225960017C90924648 @default.
• W4225960017 hasConceptScore W4225960017C98274493 @default.
• W4225960017 hasFunder F4320332161 @default.
• W4225960017 hasIssue "10" @default.
• W4225960017 hasLocation W42259600171 @default.
• W4225960017 hasLocation W42259600172 @default.
• W4225960017 hasLocation W42259600173 @default.
• W4225960017 hasOpenAccess W4225960017 @default.
• W4225960017 hasPrimaryLocation W42259600171 @default.
• W4225960017 hasRelatedWork W1975473919 @default.
• W4225960017 hasRelatedWork W1982282930 @default.
• W4225960017 hasRelatedWork W2090016234 @default.
• W4225960017 hasRelatedWork W2141289501 @default.
• W4225960017 hasRelatedWork W2347812052 @default.
• W4225960017 hasRelatedWork W2774225352 @default.
• W4225960017 hasRelatedWork W2990397977 @default.
• W4225960017 hasRelatedWork W2991030316 @default.
• W4225960017 hasRelatedWork W42711520 @default.
• W4225960017 hasRelatedWork W4364376666 @default.
• W4225960017 hasVolume "28" @default.
• W4225960017 isParatext "false" @default.

• next